Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Humanised monoclonal IgG4 antibody against tissue factor pathway inhibitor

EU orphan designation number: EU/3/12/1052   
Active ingredient: Humanised monoclonal IgG4 antibody against tissue factor pathway inhibitor
Indication: Treatment of haemophilia A
Sponsor: Novo Nordisk A/S
Novo Allé, DK-2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2012 Centralised Orphan - Designation EMA/OD/095/12 (2012)7229 of 10/10/2012